| Group I | Group II | ||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Histological feature | L-01 | L-04 | L-02 | E-01 | E-10 | E-04 | L-03 | E-06 | E-12 | E-09 | E-03 | E-02 | E-08 | E-07 | E-05 | E-11 |
Proliferation of synovial cells | 3 | 2 | 1 | 1 | 1 | 2 | 2 | 2 | 2 | 2 | 1 | 1 | 2 | 1 | 2 | 1 |
 | 1.80 ± 0.63 (1.67 ± 0.52) | 1.33 ± 0.52 | ||||||||||||||
Typical palisading | 3 | 3 | 3 | 2 | 2 | 2 | 2 | 1 | 2 | 3 | 1 | 1 | 2 | 2 | 2 | 0 |
 | 2.30 ± 0.68*(2.00 ± 0.63) | 1.33 ± 0.82 | ||||||||||||||
Non-foreign-body giant cells | 2 | 3 | 3 | 1 | 2 | 1 | 1 | 1 | 2 | 1 | 1 | 3 | 1 | 2 | 0 | 0 |
 | 1.70 ± 0.82 (1.33 ± 0.52) | 1.17 ± 0.48 | ||||||||||||||
Lymphoid cell infiltration | 3 | 1 | 3 | 0 | 2 | 1 | 2 | 1 | 1 | 2 | 0 | 0 | 0 | 0 | 0 | 0 |
 | 1.60 ± 0.97†(1.17 ± 0.75*) | 0.00 ± 0.00 | ||||||||||||||
Plasma cell infiltration | 3 | 3 | 3 | 0 | 3 | 2 | 3 | 1 | 3 | 3 | 0 | 0 | 1 | 0 | 0 | 0 |
 | 2.40 ± 1.08†(2.00 ± 1.27*) | 0.17 ± 0.41 | ||||||||||||||
Neovascularization | 2 | 2 | 2 | 2 | 2 | 2 | 3 | 2 | 2 | 3 | 3 | 3 | 2 | 2 | 1 | 3 |
 | 2.20 ± 0.42 (2.17 ± 0.41) | 2.33 ± 0.82 | ||||||||||||||
Mesenchymoid transformation | 1 | 1 | 2 | 0 | 0 | 0 | 1 | 0 | 0 | 3 | 0 | 0 | 0 | 0 | 0 | 0 |
 | 0.80 ± 1.03 (0.50 ± 1.23) | 0.00 ± 0.00 | ||||||||||||||
Fibrinoid necrosis | 1 | 3 | 2 | 0 | 0 | 0 | 1 | 0 | 1 | 2 | 0 | 0 | 1 | 0 | 1 | 0 |
 | 1.00 ± 1.05 (0.50 ± 0.84) | 0.33 ± 0.52 | ||||||||||||||
Total | 18 | 18 | 19 | 6 | 12 | 10 | 15 | 8 | 13 | 19 | 6 | 8 | 9 | 7 | 6 | 4 |
 | 13.80 ± 4.76†(11.33 ± 4.37*) | 6.67 ± 1.75 |